Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma

被引:73
作者
Kummar, S
Fogarasi, M
Canova, A
Mota, A
Ciesielski, T
机构
[1] Yale Univ, Sch Med, Ctr Canc, Dept Med, West Haven, CT 06516 USA
[2] VA Connecticut Canc Ctr, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA
[3] VA Connecticut Healthcare Syst, Dept Pathol, West Haven, CT 06516 USA
关键词
cytokeratin staining; lung adenocarcinoma; colorectal cancer; adenocarcinoma of unknown primary;
D O I
10.1038/sj.bjc.6600326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The origin of metastatic adenocarcinoma lesions can sometimes be difficult to diagnose. The objectives of our study were to establish the cytokeratin staining pattern of primary and metastatic lung and colorectal adenocarcinomas, and to determine if this helps to identify the site of origin of metastatic lesions, We reviewed a total of 102 tissue samples from patients in our tumour registry, with either primary or metastatic lung or colorectal adenocarcinoma. Tissue sections were stained for cytokeratin 7 and 20 and read as positive or negative for staining, Clinical and radiologic information was reviewed from computerised charts, The cytokeratin 7+/cytokeratin 20 - pattern characterised 96% (29 out of 30) of primary and 95% (21 out of 22) of metastatic lung adenocarcinomas. All the primary (26), and 88% (21 out of 24) of metastatic colorectal adenocarcinomas stained cytokeratin 7-/cytokeratin 20+. Samples from a variety of metastatic sites were evaluated for cytokeratin 7 and 20 staining. Out of the 102 samples, in 95% (97 out of 102) of the cases, the cytokeratin 7 and cytokeratin 20 staining pattern characterised and differentiated between lung and colorectal adenocarcinoma. Primary and metastatic lung adenocarcinomas show a cytokeratin 7+/cytokeratin 20- staining pattern, while colorectal adenocarcinomas stain cytokeratin 7-/cytokeratin 20+. Cytokeratin staining is helpful in the diagnostic differentiation of meta-static lesions from these two common primaries, and assists in determining the site of origin of metastatic lesions. (C) 2002 Cancer Research UK.
引用
收藏
页码:1884 / 1887
页数:4
相关论文
共 15 条
[1]   ANALYSIS OF A DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED TUMORS OF UNKNOWN ORIGIN [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
LENZI, R ;
HESS, KR ;
RABER, MN .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2094-2103
[2]   Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases [J].
Chu, PG ;
Wu, E ;
Weiss, LM .
MODERN PATHOLOGY, 2000, 13 (09) :962-972
[3]   Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies [J].
Goldstein, NS ;
Thomas, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (03) :319-325
[4]   Metastatic adenocarcinoma of unknown primary origin [J].
Hammar, SP .
HUMAN PATHOLOGY, 1998, 29 (12) :1393-1402
[5]   Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma [J].
Harlamert, HA ;
Mira, J ;
Bejarano, PA ;
Baughman, RP ;
Miller, MA ;
Whitsett, JA ;
Yassin, R .
ACTA CYTOLOGICA, 1998, 42 (06) :1382-1388
[6]   Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach [J].
Lagendijk, JH ;
Mullink, H ;
van Diest, PJ ;
Meijer, GA ;
Meijer, CJLM .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (04) :283-290
[7]   Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites [J].
Lagendijk, JH ;
Mullink, H ;
Van Diest, PJ ;
Meijer, GA ;
Meijer, CJLM .
HUMAN PATHOLOGY, 1998, 29 (05) :491-497
[8]   UTILITY OF CYTOKERATIN IMMUNOSTAINING IN SEPARATING PULMONARY ADENOCARCINOMAS FROM COLONIC ADENOCARCINOMAS [J].
LOY, TS ;
CALALUCE, RD .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) :764-767
[9]   ADENOCARCINOMA IN THE LUNG IN PATIENTS WITH BREAST-CANCER - A PROSPECTIVE ANALYSIS OF THE DISCRIMINATORY VALUE OF IMMUNOHISTOLOGY [J].
RAAB, SS ;
BERG, LC ;
SWANSON, PE ;
WICK, MR .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (01) :27-35
[10]   Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer [J].
Rubin, BP ;
Skarin, AT ;
Pisick, E ;
Rizk, M ;
Salgia, R .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (01) :77-82